Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
6.96
0.00 (0.00%)
At close: Jan 17, 2025, 4:00 PM
7.20
+0.24 (3.45%)
After-hours: Jan 17, 2025, 5:02 PM EST
Phathom Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for PHAT stock have an average target of 23, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 230.46% from the current stock price of 6.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PHAT stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +302.30% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +302.30% | Dec 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +302.30% | Dec 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +273.56% | Sep 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +273.56% | Sep 6, 2024 |
Financial Forecast
Revenue This Year
52.67M
from 682.00K
Increased by 7,622.43%
Revenue Next Year
178.57M
from 52.67M
Increased by 239.05%
EPS This Year
-5.70
from -3.93
EPS Next Year
-4.47
from -5.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 58.4M | 240.1M | 515.0M | |||
| Avg | 52.7M | 178.6M | 391.4M | |||
| Low | 45.8M | 134.5M | 268.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 8,460.1% | 355.8% | 188.4% | |||
| Avg | 7,622.4% | 239.1% | 119.2% | |||
| Low | 6,615.7% | 155.5% | 50.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -5.72 | -3.62 | -0.35 | |||
| Avg | -5.70 | -4.47 | -2.18 | |||
| Low | -5.59 | -5.89 | -2.79 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.